Table 2.
Six month resource use for the cohort of inflammatory bowel disease (IBD) patients
| Parameter (per 6 months) | Ulcerative colitis* | Crohn’s disease | ||
| Ambulatory group (n = 241)† | Hospitalised group (n = 27)† | Ambulatory group (n = 130)† | Hospitalised group (n = 28)† | |
| Outpatient services (visits) | ||||
| IBD related | 1.8 (0–8) | 2.8 (0–3) | 2.2 (0–7) | 2.9; (0 – 8) |
| Extraintestinal | 1.14 (1–2) | – | 1.25 (1–3) | – |
| Dietician | 0.01 (0–1) | – | 0.07 (0–3) | 0.1 (0–1) |
| Stoma nurse | 0.01 (0–1) | 0.07 (0–1) | – | 0.03 (0–1) |
| Laboratory | 5.9 (0–55) | 45.1 (5–130) | 7.6 (0–28) | 35.3 (9–66) |
| Radiology | ||||
| Plain x ray | 0.01 (0–1) | 2.1 (0–6) | 0.07 (0–1) | 1.4 (0–4) |
| Barium enema | 0.02 (0–1) | 0.03 (0–1) | 0.01 (0–1) | 0.07 (0–1) |
| Barium F/T | 0.01 (0–1) | 0.07 (0–1) | 0.1 (0–1) | 0.30 (0–2) |
| USS Abd | 0.02 (0–1) | 0.07 (0–1) | 0.02 (0–1) | 0.18 (0–1) |
| CT abdomen/pelvis | – | 0.07 (0–1) | 0.01 (0–1) | 0.01 (0–1) |
| MRI abdomen/Pelvis | – | – | – | 0.07 (0–1) |
| WBC scan | – | – | 0.01 (0–1) | 0.07 (0–1) |
| DEXA scan | 0.03 (0–1) | – | 0.07 (0–1) | – |
| Fistulogram | 0.01 (0 – 1) | |||
| Endoscopies | ||||
| OGD | 0.02 (0–1) | 0.04 (0–1) | 0.15 (0–1) | 0.11 (0–1) |
| Sigmoidoscopy | 0.14 (0–2) | 0.7 (0–4) | 0.05 (0–2) | 0.18 (0–1) |
| Colonoscopy | 0.18 (0–1) | 0.3 (0–3) | 0.1 (0–1) | 0.3 (0–3) |
| Hospital admission | ||||
| No of admissions | NA | 1.3 (1–3) | NA | 1.1 (1–2) |
| Length of each admission (days) | 18 (1–32) | 14 (4–40) | ||
Values are mean (range).
Barium F/T, barium follow through; USS Abd, ultrasound of the abdomen; CT, computed tomography; MRI, magnetic resonance imaging; WBC, white blood cell; OGD, oesophagogastroduodenoscopy.
*Includes patients with indeterminate colitis.
†Excludes incidence cases and those patients who were lost to follow up.